Filippseyjar - enska - FDA (Food And Drug Administration)

b. braun avitum phils., inc. - haemodialysis acid concentrate - haemodialysis acid concentrate

Írland - enska - HPRA (Health Products Regulatory Authority)

gambro lundia ab - magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium hydrogen carbonate; sodium chloride; sodium chloride ; calcium chloride dihydrate ; magnesium chloride hexahydrate; sodium lactate ; sodium hydrogen carbonate - solution for haemodialysis/haemofiltration - hemofiltrates

Írland - enska - HPRA (Health Products Regulatory Authority)

gambro lundia ab - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; chloride; lactase; hydrogen carbonate; potassium; glucose - solution for haemodialysis/haemofiltration - 4 millimole(s)/litre - hemofiltrates

Ísrael - enska - Ministry of Health

teva medical ltd - calcium chloride; glucose hydrous; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - glucose hydrous 1.5 g / 100 ml; calcium chloride 18.3 mg / 100 ml; sodium chloride 538 mg / 100 ml; lactic acid as sodium 448 mg / 100 ml; magnesium chloride 5.08 mg / 100 ml - combinations of electrolytes - combinations of electrolytes - for use in chronic renal failure patients being maintained in peritoneal dialysis.

Ísrael - enska - Ministry of Health

teva medical ltd - calcium chloride; glucose hydrous; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - glucose hydrous 2.5 g / 100 ml; calcium chloride 18.3 mg / 100 ml; sodium chloride 538 mg / 100 ml; lactic acid as sodium 448 mg / 100 ml; magnesium chloride 5.08 mg / 100 ml - combinations of electrolytes - combinations of electrolytes - for use in chronic renal failure patients being maintained in peritoneal dialysis.

Ísrael - enska - Ministry of Health

teva medical ltd - calcium chloride; glucose hydrous; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - glucose hydrous 4.25 g / 100 ml; magnesium chloride 5.08 mg / 100 ml; sodium chloride 538 mg / 100 ml; lactic acid as sodium 448 mg / 100 ml; calcium chloride 18.3 mg / 100 ml - electrolytes in combination with other drugs - electrolytes in combination with other drugs - for use in chronic renal failure patient being maintained in peritoneal dialysis.

Írland - enska - HPRA (Health Products Regulatory Authority)

gambro lundia ab - magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium hydrogen carbonate; sodium chloride; sodium chloride ; calcium chloride dihydrate ; magnesium chloride hexahydrate; sodium lactate ; sodium hydrogen carbonate - solution for haemodialysis/haemofiltration - hemodialytics and hemofiltrates

Írland - enska - HPRA (Health Products Regulatory Authority)

gambro lundia ab - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; chloride; lactate; hydrogen carbonate; potassium; glucose - solution for haemodialysis/haemofiltration - 4 millimole(s)/litre - hemofiltrates

Írland - enska - HPRA (Health Products Regulatory Authority)

gambro lundia ab - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; chloride; lactate; hydrogen carbonate; potassium; glucose - solution for haemodialysis/haemofiltration - 2 millimole(s)/litre - hemofiltrates

Írland - enska - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - icodextrin, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium (s)-lactate solution - soln for peritoneal dialysis - per cent - isotonic solutions - peritoneal dialytics, isotonic solutions - it is recommended as a once daily replacement for a single glucose exchange as part of a continuous ambulatory peritoneal dialysis (capd) or automated peritoneal dialysis (apd) regimen for the treatment of chronic renal failure, particularly for patients who have lost ultrafiltration on glucose solutions, because it can extend time on capd therapy in such patients.